Literature DB >> 227959

Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides.

J C Roder, M Klein.   

Abstract

Dibutyryl cAMP (dB-cAMP) and the cAMP elevating agents, prostaglandin E1, theophylline, and histamine markedly suppressed NK cytolytic function in a dose- and rate-dependent manner. The inhibition was rapidly induced and persisted in the presence of the drugs. Separate pretreatment of targets and highly purified NK cells, isolated by a target binding and velocity sedimentation technique, revealed that PGE1 and dB-cAMP acted at the level of the effector cell in a short-term cytolytic assay. In contrast to the inhibitory effects of cAMP elevating agents, dB-cGMP and carbamylcholine caused a small but significant acceleration in the rate of lysis and could compete with inhibitory doses of dB-cAMP to reduce the level of suppression thereby suggesting that the cAMP-cGMP ratio might be important in NK-mediated lysis. Insulin had no effect on NK activity, whereas T cell-mediated cytolysis was augmented by insulin and cGMP if the effector cells were taken early after alloimmunization but not later. Neither cAMP- nor cGMP-elevating agents affected the frequency of NK-target cell conjugates. These results are compatible with the hypothesis that cyclic nucleotides may be involved in triggering the lytic event within NK cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227959

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Lysis-sensitive targets stimulate an elevation of cAMP in human natural killer cells.

Authors:  M M Whalen; C B Green
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

2.  Isolation of intestinal mononuclear cells: factors released which affect lymphocyte viability and function.

Authors:  P R Gibson; A Hermanowicz; H J Verhaar; D J Ferguson; A L Bernal; D P Jewell
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

3.  Inhibition of human natural killer activity by antiserum against vitamin D-binding protein, a group-specific component (Gc).

Authors:  T Chujo; T Machii; S Tagawa; H Kuratsune; E Ueda; H Kimura; T Kitani
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

Review 4.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

5.  Inhibition of mouse natural killer activity by cyclosporin A.

Authors:  R H Yanagihara; W H Adler
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

6.  Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.

Authors:  W L Sibbitt; P M Mathews; A D Bankhurst
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  Effects of lipopolysaccharide on interleukin-2-induced cytotoxic activity of murine splenocyte cultures: role of prostaglandin E2 and interferons.

Authors:  D Vaillier; R Daculsi; N Gualde
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.

Authors:  P R Gibson; D P Jewell
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

10.  Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.

Authors:  W L Sibbitt; C J Froelich; A D Bankhurst
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.